SUMMARY A survey has been made of pregnancy occurring in patients who were attending the Ulcerative Colitis Clinic at Oxford during the 20-year period, 1960-79 inclusive. There were 256 married women of child-bearing age who attended during this period. Of these, 100 were excluded from the survey for various reasons, such as that they had completed their family before the onset of the ulcerative colitis, had already had an hysterectomy, or had a proctocolectomy before their first pregnancy. Of the remaining 156 patients, nine could not be traced. Full details were obtained from 147 patients, virtually all of whom were interviewed. The fertility of these patients was normal.
SUMMARY A survey has been made of pregnancy occurring in patients who were attending the Ulcerative Colitis Clinic at Oxford during the 20-year period, 1960-79 inclusive. There were 256 married women of child-bearing age who attended during this period. Of these, 100 were excluded from the survey for various reasons, such as that they had completed their family before the onset of the ulcerative colitis, had already had an hysterectomy, or had a proctocolectomy before their first pregnancy. Of the remaining 156 patients, nine could not be traced. Full details were obtained from 147 patients, virtually all of whom were interviewed. The fertility of these patients was normal.
Of the 147 women, 119 (81 %) had conceived and only 10 (6-8 %) were involuntarily infertile. The size of family approximated to that found in the general British population. The overall outcome of the pregnancies was similar to that in the general British population. The patients in whom the disease was quiescent at the start of pregnancy fared particularly well. Those with active disease had a somewhat lower chance of producing a normal live baby. The small group of patients in whom the disease was severe had a much lower chance of a normal outcome. Patients in whom the ulcerative colitis was quiescent at the beginning of pregnancy had a good chance of remaining symptom-free throughout the pregnancy and puerperium. Even if the colitis recurred, it was likely to be mild and responsive to medical treatment. By contrast, when the ulcerative colitis was active at the start of pregnancy, most patients continued to have symptoms in spite of medical treatment. Some patients had their first attack of ulcerative colitis during pregnancy or the puerperium. In contrast to previous experience the attacks were Methods PATIENTS During the period under survey, a total of 256 married women below the age of 45 years attended the Ulcerative Colitis Clinic. Of these 256 patients, 100 were excluded for the following reasons: In 91 patients, the family was complete before the onset of ulcerative colitis. In five patients, a hysterectomy had been performed before the onset of ulcerative colitis. In three patients, a proctocolectomy with permanent ileostomy had been carried out before their first pregnancy. (Some other patients had pregnancies both before and after a proctocolectomy with permanent ileostomy and we have excluded any post-ileostomy pregnancies in our analysis.) One patient, whose ulcerative colitis had begun in childhood, ceased to attend the clinic on moving to another area and subsequently died before having a family.
Of the remaining 156 patients, nine have not been 
EFFECT OF ULCERATIVE COLITIS ON PREGNANCY
During the 20-year period under review, there were 216 pregnancies among the 119 married women who conceived. Table 1 shows that the vast majority of the pregnancies resulted in normal live births. Among these, there were 12 babies who were of low birth weight (less than 2-5 kg) but who then developed normally. The proportion of babies of low birth weight in our entire series is similar to that occurring in the general population.8 Seven of the women were still pregnant at the end of the period of study and in all these patients the pregnancy was proceeding uneventfully.
Five children were abnormal at birth. Two of them suffered from cerebral palsy; one of these was delivered normally but was premature, while the other was also premature but was delivered by Caesarean section because of failure of fetal growth. Among the other three infants, one had congenital dislocalion of the hips which has been treated successfiully by splints, and the remaining two both had hypospadias which will need surgical correction. figure. 10
Nine of the pregnancies were t therapeutic abortion. In five, the performed for social reasons not coI ulcerative colitis. In the remaining became more active in the first tri termination of pregnancy was advi grounds, in two cases by specialists the general practitioner. No wom; by us to have her pregnancy termii There were two stillbirths, one of in another hospital after a proloi three days' duration, while the othei and there was severe fetal distress rate of 9 per 1000 births is well wit} figure.
Apart from the two stillbirths, perinatal deaths. The total perinata therefore 9 per 1000 births, which is rate for the Oxford region in Table 3 shows our own data classified according to the above scheme. Out of the 129 pregnancies in erminated by a which the colitis was quiescent at the time of conabortion was ception, 90 (69.8%) of the patients remained free nnected with the from colitic symptoms throughout pregnancy and four, the colitis the puerperium. In the remaining 39 pregnancies, imester and the relapse occurred and this was most likely in the first ised on medical trimester, a finding which agrees with previous and in two by observations.256 There were six patients who rean was advised mained free from symptoms during pregnancy but nated.
who relapsed in the puerperium; an additional which occurred three patients had an attack of colitis in the puernged labour of perium as well as having had a relapse during the r was premature pregnancy. Some earlier workers found that relapse , . This stillbirth was particularly common during the puerperium but hin the expected the present results show that this is no longer the case.
there were no When pregnancy occurred in patients with active l mortality was ulcerative colitis, the course of the colitis was less s lower than the favourable. Out of 55 pregnancies in this category, which was itself in only a minority did the disease become quiescent lowest rate in (13) Taking the 129 pregnancies occurring when the ulcerative colitis was quiescent, they can be divided into those during which the patient was on maintenance therapy with sulphasalazine throughout the entire pregnancy and those in which no sulphasalazine was used. Of the six babies with pathological jaundice, five were treated with ultraviolet light therapy and the only one who required exchange transfusion was born to a mother not receiving sulphasalazine.
Taking the patients whose ulcerative colitis was clinically active at some stage during pregnancy, any therapy they received and the outcome of the pregnancy is summarised in Table 6 . It can be seen that, in general, the more extensive the treatment the more likely it was that the pregnancy would not proceed to a normal live birth. This is particularly shown in the patients who were treated with a combination of oral corticosteroids, topical corticosteroids, and sulphasalazine. The generally un- Table 6 Outcome ofpregnancy in relation to treatment of active ulcerative colitis during pregnancy favourable course in this group of patients was probably due to the severity of the ulcerative colitis rather than to the effects of medical therapy. It is interesting that pathological jaundice was no more frequent in the babies of patients who received sulphasalazine than in those of patients who did not.
It is somewhat disturbing that there were three cases of congenital abnormality in the babies born to the 54 mothers treated with sulphasalazine, whereas there were none in the 50 whose mothers had received either no treatment or corticosteroids alone. However, we have already shown that, when the ulcerative colitis was quiescent at the start of pregnancy, treatment with sulphasalazine had no effect on the risk of producing a congenitally abnormal child (Table 5) . We therefore consider it more likely that the clinical activity of the ulcerative colitis was the responsible factor rather than the use of sulphasalazine as treatment.
Discussion
The present study has provided definite answers to the four questions posed in the introduction to this article.
FERTILITY
Women with ulcerative colitis appear to have a normal chance of becoming pregnant. This conclusion has been reached by various authors of previous studies but on the basis of inadequate data. In our own series, the overall rate of involuntary infertility (6.8%) is similar to that estimated for the general population in this country (10% If the ulcerative colitis is quiescent at the start of pregnancy, there is a good chance that the disease will remain in remission throughout pregnancy and the puerperium. If relapse does occur, this is most likely to happen in the first trimester. Even if relapse occurs, the risk to the mother is nowadays negligible, provided that the ulcerative colitis is treated vigorously.
Women with ulcerative colitis which is symptomatic at the start of pregnancy are likely to continue to have symptoms throughout the pregnancy in spite of medical treatment. This provides an additional reason for advising married women with this disease to avoid, as far as possible, becoming pregnant while the ulcerative colitis is active.
We have found no undue liability of patients with established ulcerative colitis to suffer from a relapse of the disease during the puerperium, a result which conflicts with previous findings.
It was previously found that when ulcerative colitis began during pregnancy or the puerperium, it was frequently severe. This has not been our own recent experience and this may reflect the beneficial effects of modern medical treatment.
In the past, it has been suggested that a severe attack of ulcerative colitis occurring in the first trimester of pregnancy should be regarded as an indication for therapeutic abortion.12 Our own experience is opposed to this view. Although four of our patients had a pregnancy terminated on medical advice, there was no evidence that this procedure improved the course of the colitis and we judge that it is preferable to treat the disease in the same way as one would in a non-pregnant patient.
EFFECT OF TREATMENT
The married women in our present series suffered from no maternal mortality, were normally fertile, and usually produced a normal live baby. This is prima facie evidence that modern medical treatment has been beneficial but it is difficult to assemble proof with the type of study now presented.
There was no evidence that any of the mothers were harmed by the medical treatments employed, which were essentially corticosteroids and sulphasalazine. As far as the fetus is concerned, animal experiments have suggested that the use of corticosteroids may lead to spontaneous abortion or to congenital abnormalities4 15 but studies in man have yielded contradictory results. '6 17 In the present survey, there was no indication that the use of corticosteroids was associated with any enhanced risk of congenital abnormalities. Although systemic corticosteroid therapy has been implicated in the production of placental insufficiency,'7 the incidence of low birth-weight babies in this survey was the same in mothers who had received steroid treatment during pregnancy (18-9%) as in those with active ulcerative colitis who had not done so (18.3%).
The main theoretical risk of using sulphasalazine throughout pregnancy and the puerperium is that the baby might suffer from kernicterus.18 Sulphasalazine and its principal metabolites are known to cross the placenta18l9 and could displace unconjugated bilirubin from binding sites on plasma albumin. Sulphapyridine also enters breast milk.'920 However, no evidence has been found of any adverse clinical effects on the children born to our patients during the past 20 years and there are no recorded cases in the literature.
Recommendations
The results of the present survey enable us to make two practical recommendations:
1. Whenever feasible, a woman with ulcerative colitis should plan her family so that she conceives only when the disease is quiescent.
2. Active ulcerative colitis during pregnancy should be treated with corticosteroids and sulphasalazine in the same way as in non-pregnant patients.
